Global Pharmaceutical Technology :: A Best B2B solution, Best Media Portal for Pharmaceutical Industry.

A recent study conducted by Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. revealed that a staggering 43% of critical and major product deficiencies are directly related to ineffective temperature control and monitoring during transportation and storage. The World Health Organization (WHO) also recently suggested that 25% of all vaccine products arrive at their final destination in a degraded state.

Given the high cost of conducting global clinical trials and the even higher cost of failure, regulatory agencies and pharmaceutical companies alike now demand that every party involved in the pharmaceutical supply chain − transportation and logistics providers included − conform to GxP guidelines.

for more details download whitepaper